You just read:

New Whitepaper Identifies Reasons Why ICER's Cost-Effectiveness Analyses Are Not Useful for Payers

News provided by

Pharmaceutical Research and Manufacturers of America (PhRMA)

Sep 19, 2018, 05:37 ET